Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUSRecruiting
NCT05795140Phase 3Updated Jun 4, 2026
Sponsor: Novartis Pharmaceuticals
Atypical Hemolytic Uremic Syndrome
Brazil, China, Czechia, India, Japan +1 more
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder SymptomsRecruiting
NCT05878951Phase 2, Phase 3Updated Jun 4, 2026
Sponsor: Northwestern University
Urinary Incontinence · Overactive Bladder Syndrome · Overactive Bladder · Urologic Diseases
United States
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in AdultsRecruiting
NCT07382167Phase 3Updated Jun 4, 2026
Sponsor: Ardelyx
Chronic Idiopathic Constipation (CIC)
United States
Ketofol Versus Ketodex for POD Prophylaxis in Elderly Cancer SurgeryRecruiting
NCT07627906Phase 3Updated Jun 4, 2026
Sponsor: Cairo University
Postoperative Delirium (POD)
Egypt
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia GravisRecruiting
NCT06392386Phase 2, Phase 3Updated Jun 4, 2026
Sponsor: argenx
Generalized Myasthenia Gravis
United States, Belgium, Canada, Czechia, France +8 more
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)Recruiting
NCT07625332Phase 2, Phase 3Updated Jun 4, 2026
Sponsor: Northwell Health
Spinal Cord Injury · Traumatic Spinal Cord Injury · Paraplegia and Tetraplegia · Metabolic Syndrome
United States
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical HyperplasiaRecruiting
NCT05316493Phase 2, Phase 3Updated Jun 4, 2026
Sponsor: Xiaojun Chen
Atypical Endometrial Hyperplasia · Fertility Issues · Overweight and Obesity
China
Buprenorphine for Individuals in JailRecruiting
NCT06306443Phase 3Updated Jun 4, 2026
Sponsor: Friends Research Institute, Inc.
Opioid Use Disorder
United States
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell TransplantationRecruiting
NCT05243797Phase 3Updated Jun 4, 2026
Sponsor: European Myeloma Network B.V.
Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +20 more
Chemotherapy With Rituximab for Aggressive B-NHL in Children and AdolescentsRecruiting
NCT07168980Phase 2, Phase 3Updated Jun 4, 2026
Sponsor: Children's Cancer Group, China
Mature B-cell Non-Hodgkin Lymphoma
China
A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast CancerRecruiting
NCT07518173Phase 3Updated Jun 4, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
HER2-positive Breast Cancer
China
Volatile Sedation for Patients With the Acute Respiratory Distress SyndromeRecruiting
NCT06014138Phase 2, Phase 3Updated Jun 4, 2026
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Acute Respiratory Distress Syndrome · Mechanical Ventilation Complication · Sedation Complication
United Kingdom
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors TrialRecruiting
NCT03011684Phase 3Updated Jun 4, 2026
Sponsor: University of California, San Francisco
Infertility
United States
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast CancerRecruiting
NCT07047365Phase 3Updated Jun 3, 2026
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
HER2-positive Advanced Breast Cancer
China
A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)Recruiting
NCT07139873Phase 3Updated Jun 3, 2026
Sponsor: Dizal Pharmaceuticals
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
China
Hydrocortisone Plus Fludrocortisone in High-risk Patients Undergoing for Cardiac SurgeryRecruiting
NCT07037043Phase 3Updated Jun 3, 2026
Sponsor: Centre Hospitalier Universitaire, Amiens
Inflammation in Cardiac Surgery
France
Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep ApneaRecruiting
NCT07332442Phase 3Updated Jun 3, 2026
Sponsor: Yale University
Sleep Apnea · Obstructive Sleep Apnea
United States
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or DeliveryRecruiting
NCT04918173Phase 3Updated Jun 3, 2026
Sponsor: Octapharma
Congenital Antithrombin Deficiency
United States, Armenia, Austria, Czechia, France +9 more
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)Recruiting
NCT07172516Phase 3Updated Jun 3, 2026
Sponsor: Xenon Pharmaceuticals Inc.
Bipolar Disorder · Bipolar Depression · Bipolar I Disorder · Bipolar II Disorder
United States
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer ProgressionRecruiting
NCT06112990Phase 3Updated Jun 3, 2026
Sponsor: University of Utah
Metastatic Prostate Cancer
United States
Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft FailureRecruiting
NCT06235892Phase 3Updated Jun 3, 2026
Sponsor: Nantes University Hospital
Organ Grafts
France, Norway, Spain
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)Recruiting
NCT06525220Phase 3Updated Jun 2, 2026
Sponsor: Merus B.V.
Head and Neck Squamous Cell Carcinoma
United States, Argentina, Australia, Belgium, Brazil +23 more
A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.Recruiting
NCT07354022Phase 3Updated Jun 2, 2026
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Locally Advanced or Metastatic Breast Cancer
China
A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.Recruiting
NCT07543380Phase 3Updated Jun 2, 2026
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
Japan
Baricitinib in Patients With Relapsing or naïve DermatomyositisRecruiting
NCT04972760Phase 3Updated Jun 2, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Dermatomyositis
France

Previous page Next page